“Introduction of new vaccines, rise in aging population, severity of influenza viruses and numerous vaccines in pipeline will thrive the global influenza market”, says RNCOS.
Noida, UP -- (SBWIRE) -- 05/12/2015 -- According to a new research report by RNCOS entitled, "Global Influenza Vaccine Market Outlook 2020", US industry has been witnessing higher growth in global influenza vaccine industry, in 2014, US influenza vaccine market accounted for over 50% of the global influenza vaccine industry market, generating approximately US$ 1.6 Billion revenue.
Introduction of innovative vaccines produced through technologically advanced techniques are helping countries to increase their vaccine coverage ratio. More and more people are becoming aware of these technically advanced vaccines and are receiving them to get rid - off the consequences of influenza viruses. However industry faces some challenges as well such as low awareness, lengthy vaccine development procedure and testing and regulatory issues. Companies such as Sanofi Pasteur, GSK, Novartis, CSL and AstraZeneca are considered to be the larger players whereas small players in the market are Protein Science, Sinovac, Serum Institute of India etc.
The report is spread in over 85 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Global Influenza Vaccine Industry. The study presents transparent picture major influenza vaccines such as FluMist, Flucelvax, Afluria, Fluzone, Fluarix and Anflu including the factors affecting their growth. The research further covers global influenza vaccine industry, detailed analysis of geographical segments, pipeline analysis, pricing analysis as well as Mergers and Acquisitions.
The report also covers detailed information about active market players in the Global Influenza Vaccine Industry, including small and large players to enable the clients understand the market structure and its growth during the forecasted period. In brief, the report covers all the necessary aspects of the global influenza vaccine industry, providing an in-depth research and prudent analysis of the key segments.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM743.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.